Serenoa repens (Bartram) Small

Sat, 19 Apr 2008 12:00:37 +0200


  • Breu W Hagenlocher M Redl K Tittel G Stadler F Wagner H (1992) [Anti-inflammatory activity of sabal fruit extracts prepared with supercritical carbon dioxide. In vitro antagonists of cyclooxygenase and 5-lipoxygenase metabolism] Antiphlogistische Wirkung eines mit hyperkritischem Kohlendioxid gewonnenen Sabalfrucht-Extraktes. In-vitro-Hemmung des Cyclooxygenase- und 5-Lipoxygenase-Metabolismus. Arzneimittelforschung 42(4):547-51
  • Carilla E Briley M Fauran F Sultan C Duvilliers C (1984) Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate. J Steroid Biochem 20(1):521-3
  • Casarosa C Cosci di Coscio M Fratta M (1988) Lack of effects of a lyposterolic extract of Serenoa repens on plasma levels of testosterone, follicle-stimulating hormone, and luteinizing hormone. Clin Ther 10(5):585-8
  • Delos S Carsol JL Ghazarossian E Raynaud JP Martin PM (1995) Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts. J Steroid Biochem Mol Biol 55(3-4):375-83
  • Delos S Iehle C Martin PM Raynaud JP Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells.J Steroid Biochem Mol Biol (1994) 48(4):347-52
  • Denis LJ (1996) Prostate 29: 241-242
  • Di Silverio F D'Eramo G Lubrano C Flammia GP Sciarra A Palma E Caponera M Sciarra F (1992) Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. Eur Urol 21(4):309-14
  • Duke, JA.(1999) Phytochemical database.
  • el-Sheikh MM Dakkak MR Saddique A (1988) The effect of Permixon on androgen receptors.: Acta Obstet Gynecol Scand 67(5):397-9
  • Hiermann A (1989) [The contents of sabal fruits and testing of their anti-inflammatoryeffect] Arch Pharm (Weinheim) 322(2):111-4
  • Lehle C Delos S Guirou O Tate R Raynaud JP Martin PM (1995) Human prostatic steroid 5 alpha-reductase isoforms--a comparative study of selective inhibitors. J Steroid Biochem Mol Biol 54(5-6):273-9
  • Mills, SY (1991) The essential book of herbal medicine Penguin-Arkana, London
  • Paubert-Braquet M, Mencia Huerta J-M, Cousse H et al (1997) Prostagland Leukot Essent Fatty Acids
  • Plosker GL Brogden RN (1996) Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia. Drugs Aging 9(5):379-95
  • Ravenna L Di Silverio F Russo MA Salvatori L Morgante E Morrone S Cardillo MR Russo A Frati L Gulino A Petrangeli E (1996) Effects of the lipidosterolic extract of Serenoa repens (Permixon) on humanprostatic cell lines. Prostate 29(4):219-30
  • Rhodes l, Primka RL, Berman C et al (1993) Prostate 22(1): 43-51
  • Stenger A, Tarayre JP, Carilla E et al (1982) Gaz Med de France 89(17):
  • Strauch G Perles P Vergult G Gabriel M Gibelin B Cummings S Malbecq W Malice MP (1994) Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers. Eur Urol 26(3):247-52
  • Sultan C Terraza A Devillier C Carilla E Briley M Loire C Descomps B (1984) Inhibition of androgen metabolism and binding by a liposterolic extract of ""Serenoa repens B"" in human foreskin fibroblasts. J Steroid Biochem 20(1):515-9
  • Tarayre JP, Delhon A, Lauressergues H, et al: (1983) Anti-edematous action of ahexane extract of the stone fruit of Serenoa repens Bartr. Ann Pharm Franc41:559-70
  • Wagner H, Flachsbarth H (1981) Planta Medica 41(3): 244-251
  • Weisser H, Behnke B, Helpap B, et al (1997) Eur Urol 26(3): 247-252
  • Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C (1998) Saw Palmetto extracts for treatment of benign prostatic hyperplasia JAMA 158(18):
Sat, 19 Apr 2008 12:00:37 +0200


Licenza Creative Commons
Il database InfoErbe
è pubblicato con
Licenza Creative Commons

Marco Valussi
Luciano Posani

Copyright 2000 - 2005 Miro International Pty Ltd. All rights reserved. Mambo is Free Software released under the GNU/GPL License.